รายการวัตถุออกฤทธิ์ประเภท 2
(Psychotropic Substance Schedule2)

• Appetite suppressant in the treatment of obesity.
• Appetite suppressant in the treatment of obesity.
• Short-term (up to 4 weeks) supportive treatment of alimentary obesity.
• Short-term management of insomnia, as a premedicant in surgical procedures, and for induction of anaesthesia.
• Insomnia characterized by difficulty in falling asleep, frequent nocturnal awakening or early morning awakenings.
• Symptomatic relief of nasalcongestion. Motion sickness, postoperative nausea, vomiting.
• Short-term management of insomnia. Premedication.
• Anaesthesia for diagnostic or short surgical operations that do not require skeletal muscle relaxation; induction of anaesthesia.
• Treatment of narcolepsy. Treatment of mood disorders. Adjunct to psychological, educational and social measures in the treatment of hyperactivity disorders in children.
• For Premedication prior to general anaesthesia or as sedative cover for minor surgical or investigative procedures. Induction of anaesthesia; patients in intensive care requiring continuous sedation. Short-term management of insomnia.
• Short-term treatment of insomnia, epilepsy. Notably for infantile spasms.
• Treatment of moderate to severe obesity.
• Treatment of moderate to severe obesity.
• Symptomatic treatment of nasal congestion. Relief of cough and cold symptoms.
• Short-term management of insomnia. Premedication before surgical or investigative procedures.
• Short-term management of insomnia.

สนใจรายละเอียดเพิ่มเติมติดต่อ narcotic@fda.moph.go.th